Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
48.6%
% of BHCHX's 40 holdings also in XLV
29.0%
% of XLV's 62 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus XLV)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BHCHX |
Weight in XLV |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY AND COMPANY | 9.3% | 11.3% | 9.3% |
|
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 10.5% | 7.3% |
|
MERCK & CO., INC. | 4.8% | 4.7% | 4.7% |
|
THERMO FISHER SCIENTIFIC INC | 4.7% | 3.8% | 3.8% |
|
INTUITIVE SURGICAL, INC. | 5.8% | 3.6% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to XLV
 |
ARGENX SE ADR | 4.1% |
 |
ICON PLC | 3.2% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
|
BOSTON SCIENTIFIC CORPORATION | 2.8% |
|
ARCELLX, INC. | 2.6% |
|
ROCKET PHARMACEUTICALS, INC. | 2.3% |
|
VERTEX PHARMACEUTICALS INCORPORATED | 2.3% |
|
VERTEX PHARMACEUTICALS INC | 2.3% |
|
THE COOPER COMPANIES, INC. | 2.2% |
|
COOPER COS INC/THE | 2.2% |
BHCHX Underweight Relative to XLV
|
JOHNSON & JOHNSON | -7.1% |
|
ABBVIE INC | -5.6% |
|
ABBOTT LABORATORIES | -3.9% |
|
UNITEDHEALTH GROUP INCORPORATED | -3.2% |
|
UNITEDHEALTH GROUP INC | -3.2% |
|
AMGEN INC | -2.9% |
|
PFIZER INC | -2.7% |
|
BRISTOL-MYERS SQUIBB CO | -2.2% |
|
MEDTRONIC PLC | -2.2% |
|
GILEAD SCIENCES INC | -2.1% |